Related Experiment Video
Updated: Aug 6, 2026

Isolation of Regenerating Hepatocytes after Partial Hepatectomy in Mice
Published on: December 2, 2022
Coffee consumption and reduced risk of hepatocellular carcinoma among patients with chronic type C liver disease: A
Satoko Ohfuji1, Wakaba Fukushima, Takashi Tanaka
1Department of Public Health, Osaka City University Graduate School of Medicine, 1-4-3, Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan.
Insights
Daily coffee consumption may protect against liver cancer in individuals with hepatitis C virus (HCV) infection. This study found lower hepatocellular carcinoma (HCC) risk in coffee drinkers with chronic liver disease.
Area of Science:
- Hepatology
- Gastroenterology
- Oncology
Background:
- Hepatocellular carcinoma (HCC) is a significant global health concern.
- Hepatitis C virus (HCV) infection is a primary risk factor for HCC development.
- The role of coffee consumption in HCC risk among HCV-infected individuals remains under-investigated.
Purpose of the Study:
- To investigate the association between coffee consumption and HCC risk in patients with chronic HCV infection.
- To evaluate coffee's potential protective effect against HCC in a high-risk population.
Main Methods:
- A hospital-based case-control study was conducted.
- 73 HCC cases and 253 controls, all with chronic HCV infection, were included.
- Conditional logistic regression analysis was used to estimate odds ratios (OR) and 95% confidence intervals (CI) for HCC risk, considering coffee intake before and after liver disease diagnosis.
Main Results:
- Daily coffee intake (≥1 cup/day) was associated with reduced HCC risk compared to non-drinkers, both before (OR 0.38) and after (OR 0.19) liver disease identification.
- This inverse correlation persisted even after excluding participants who altered their coffee intake post-diagnosis (OR 0.35).
Conclusions:
- Coffee consumption may act as a protective factor against hepatocellular carcinoma in individuals infected with the hepatitis C virus.
- Findings suggest a potential benefit of regular coffee intake for liver cancer prevention in HCV patients.
Abstract:
Several studies have reported the role of coffee for hepatocellular carcinoma (HCC). However, no study investigated about the relation of coffee for HCC among individuals with a relevant risk factor, i.e., hepatitis C virus (HCV) infection. Thus, we conducted a hospital-based case-control study to assess an association between coffee and HCC, in which both 73 cases and 253 controls were patients with chronic type C liver disease. To consider potential changes in coffee intake due to progression of liver disease, the effect of coffee was estimated separately before and after first identification of liver disease. Odds ratios (OR) and 95% confidence intervals (CI) for HCC risk were calculated using the conditional logistic regression model. Coffee drinking on a daily basis (>/=1cup/day) revealed lowered ORs as compared with non-drinkers both before first identification of liver disease (OR 0.38; 95% CI: 0.13-1.12; P=0.078) as well as thereafter (OR 0.19; 95% CI: 0.05-0.71; P=0.032). Even after excluding subjects who reported a reduction in the frequency of coffee intake after first identification of liver disease, this negative correlation persisted (OR 0.35; 95% CI: 0.12-1.06; P=0.063). Taken together, coffee may be a protective factor for HCC among those infected with HCV.
Related Concept Videos
Cancer Prevention
Some...
Cirrhosis I: Introduction
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
